Literature DB >> 20186060

In-vivo normothermic recirculation: an update.

Juan Carlos García-Valdecasas1, Constantino Fondevila.   

Abstract

PURPOSE OF REVIEW: The use of nonheart-beating donors (NHBD), as a source for liver grafts, is the only way to objectively increase the activity in liver transplantation. Through the use of more strict criteria, 1-year graft survival has increased from 50% in initial series to 84-100%. With respect to type II NHBD (failure of cardiopulmonary resuscitation) we believe that the use of normothermic recirculation provides the possibility to obtain good quality grafts for transplantation. Our recent experience shows a 66% and 73% graft and patient survival respectively. RECENT
FINDINGS: However, the incidence of biliary tract complications (ischemic type), as well as the relative low number of grafts procured that are finally transplanted, makes this methodology difficult to develop. The use of a 'normothermic machine perfusion' (once the liver is procured), added to the already described method, may actually increase the efficacy and safety of the whole procedure. Recent experience by our group as well as others have shown that the liver so perfused is able to recover from the warm ischemic lesion and at the same time the procedure allows the possibility to evaluate the quality of the potential graft.
SUMMARY: NHBD are the only source that may objectively increased the number of liver transplant. The use of normothermic recirculation has proved to be effective and well tolerated. The addition of the 'normothermic machine perfusion' to the whole procedure may significantly increase the number of transplants.

Entities:  

Mesh:

Year:  2010        PMID: 20186060     DOI: 10.1097/MOT.0b013e3283373488

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  8 in total

Review 1.  Bioengineering in organ transplantation: targeting the liver.

Authors:  K Fukumitsu; H Yagi; A Soto-Gutierrez
Journal:  Transplant Proc       Date:  2011 Jul-Aug       Impact factor: 1.066

Review 2.  Perfusion machines for liver transplantation: technology and multifunctionality.

Authors:  Michele Rubbini
Journal:  Updates Surg       Date:  2013-09-20

3.  Flow distribution during infusion of UW and HTK solution in anaesthetised rats.

Authors:  Leif Jansson; Per-Ola Carlsson; Birgitta Bodin; Orjan Källskog
Journal:  Langenbecks Arch Surg       Date:  2011-02-16       Impact factor: 3.445

4.  SIMPLE MACHINE PERFUSION SIGNIFICANTLY ENHANCES HEPATOCYTE YIELDS OF ISCHEMIC AND FRESH RAT LIVERS.

Authors:  Maria-Louisa Izamis; Candice Calhoun; Basak E Uygun; Maria Angela Guzzardi; Gavrielle Price; Martha Luitje; Nima Saeidi; Martin L Yarmush; Korkut Uygun
Journal:  Cell Med       Date:  2013

Review 5.  The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models.

Authors:  M Mendes-Braz; M Elias-Miró; M B Jiménez-Castro; A Casillas-Ramírez; F S Ramalho; C Peralta
Journal:  J Biomed Biotechnol       Date:  2012-05-09

6.  Evaluation of Liver Quality after Circulatory Death Versus Brain Death: A Comparative Preclinical Pig Model Study.

Authors:  Jérôme Danion; Raphael Thuillier; Géraldine Allain; Patrick Bruneval; Jacques Tomasi; Michel Pinsard; Thierry Hauet; Thomas Kerforne
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

7.  A simplified subnormothermic machine perfusion system restores ischemically damaged liver grafts in a rat model of orthotopic liver transplantation.

Authors:  Tim A Berendsen; Bote G Bruinsma; Jungwoo Lee; Vincent D'Andrea; Qiang Liu; Maria-Louisa Izamis; Korkut Uygun; Martin L Yarmush
Journal:  Transplant Res       Date:  2012-05-09

8.  Non-invasive magnetic resonance imaging in rats for prediction of the fate of grafted kidneys from cardiac death donors.

Authors:  Jun-Ya Kaimori; Satomi Iwai; Masaki Hatanaka; Takumi Teratani; Yoshitsugu Obi; Hidetoshi Tsuda; Yoshitaka Isaka; Takashi Yokawa; Kagayaki Kuroda; Naotsugu Ichimaru; Masayoshi Okumi; Koji Yazawa; Hiromi Rakugi; Norio Nonomura; Shiro Takahara; Eiji Kobayashi
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.